Align Technology Announces $150 Million Open Market Repurchase
Align Technology recently announced that it is planning to repurchase $150 million of Align*s common stock through open market repurchases under Align*s $1.0 billion stock
Align Technology recently announced that it is planning to repurchase $150 million of Align*s common stock through open market repurchases under Align*s $1.0 billion stock
Dr Sandeep Kumar shares his thoughts about the challenges that Dental Practice Accelerator winner Hannan Saleem and his practice face and provides his insights and

Align Technology, Inc. (NASDAQ: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners,

Align Technology announced that Align’s Invisalign Palatal Expander System* has been included in the Australian Register of Therapeutic Goods (ARTG) and the New Zealand Web

Align Technology announced that it will report first-quarter 2024 financial results on Wednesday, April 24, 2024, after the close of the market. Financial results will

Align Technology announced that it has completed the acquisition of privately-held Cubicure GmbH, a pioneer in direct 3D printing solutions for polymer additive manufacturing that

Align Technology announced that it will report fourth-quarter and 2023 financial results on Wednesday, January 31, 2024, after the close of the market. Financial results

A federal court issued this notice; it is not a solicitation from a lawyer. A class action lawsuit has been filed against Align Technology, Inc.

Align Technology announced the launch of its 2024 Annual Research Award Program, aimed at supporting clinical and scientific dental research at universities worldwide. This year,
Driven by his commitment to an evidence-based approach and cutting-edge technologies, at the Align UKI Forum Dr Simon Chard offered insights into the future of

Align Technology has entered into a new accelerated stock repurchase agreement (ASR) with Citibank, N.A. (‘Citi’) to repurchase $250 million of Align’s common stock as
Discover how to optimise Invisalign treatment for children and teen patients. This is a masterclass exclusively for specialist orthodontic Invisalign providers looking to achieve predictable